PSMB9 and infarction: Our previous work found that the immunoproteasome is involved in the pathophysiology of ischemia stroke, while inhibition of LMP2 suppresses proinflammatory cytokine production, reduces infarction volumes and enhances angiogenesis in a rat ischemia stroke model [9, 10].